Both cholesterol and fatty acid metabolism are enriched in cancer stem cells and have been associated with stem cell signaling and therapy resistance in many cancers20,50,51, indicating that SMARCD3 may regulate stem cell-enriched metabolic pathways. Here, SMARCD3 is linked to cancer.